COMPANY

SynCardia Systems

Status: Acquired, now part of Picard Medical · How status works

Location: Tucson, AZ · source · Oct 15, 2026

Profile checked Oct 10, 2026

Keywords: Biventricular Failure Life-threatening Biventricular Heart Failure Ineligible for Cardiac Transplant Bi-ventricular Failure Right-Sided Heart Failure Cardiac Failure Left-Sided Heart Failure 70cc TAH-t for Destination Therapy SynCardia 50cc temporary Total Artificial Heart (TAH-t) CardioWest temporary Total Artificial Heart (TAH-t) CardioWest temporary Total Artificial Heart (TAH-t) System

5Trials (company is sponsor)

Funding and NIH signals

NIH award NIH awarded $606K (SBIR Phase I 1R43HL184460-01, new, notice Aug 28, 2026). NIH RePORTER 1R43HL184460-01 (Aug 28, 2026)
Evidence (1 event)
- Aug 28, 2026 · NIH RePORTER 1R43HL184460-01
  Organization: SYNCARDIA SYSTEMS, LLC; City/State: Tucson, AZ; Project number: 1R43HL184460-01; Activity code: R43; Fiscal year: 2026; Award notice date: 2026-08-28; FY total cost (award amount): 606498; Administering IC: National Heart Lung and Blood Institute; Project title: A wearable, mechanically actuated total artificial heart (Emperor) enabling destination therapy for severe biventricular heart failure patients; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

Timeline

2016-02 Trial start Not phased (device or behavioral study): SynCardia 70cc TAH-t for Destination Therapy (DT) source ↗
2015-10 Trial start Not phased (device or behavioral study): Syncardia 50cc TAH-t as a Bridge to Transplant source ↗
2013-12 Trial start —: SynCardia Companion 2 Driver System Post Approval Study Protocol With INTERMACS™-Based Data Collection source ↗
2010-03 Trial start —: SynCardia Freedom Driver System Study source ↗
2006-08 Trial start —: SynCardia CardioWest TAH-t Postmarket Surveillance Study source ↗

Clinical trials (lead sponsor) 5

Record	Title	Phase	Status	Start	Primary completion
NCT02232659	SynCardia 70cc TAH-t for Destination Therapy (DT)	Not phased (device or behavioral study)	Unknown status (ClinicalTrials.gov)	2016-02	2021-12 (estimated)
NCT01919320	SynCardia Companion 2 Driver System Post Approval Study Protocol With INTERMACS™-Based Data Collection	Not listed	Unknown status (ClinicalTrials.gov)	2013-12	2022-12 (estimated)
NCT02459054	Syncardia 50cc TAH-t as a Bridge to Transplant	Not phased (device or behavioral study)	Terminated	2015-10	Jul 29, 2020 (actual)
NCT00614510	SynCardia CardioWest TAH-t Postmarket Surveillance Study	Not listed	Completed	2006-08	2015-03 (actual)
NCT00733447	SynCardia Freedom Driver System Study	Not listed	Approved for marketing	2010-03	2013-08 (actual)